Lebenthal Global Advisors’s Amgen AMGN Stock Holding History

Lebenthal Global Advisors’s Portfolio AMGN Stock Details AMGN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q2	–	Sell	-200	Closed	-$56.9K	–	181
2024 Q1	$56.9K	Buy	+200	New	+$58.5K	0.01%	185

Other funds holding AMGN

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

Lebenthal Global Advisors's AMGN Position: Q1 2026 in Review

Lebenthal Global Advisors reduced its Amgen (AMGN) stake by 0.5% in Q1 2026, selling an estimated $10.3K and leaving 5,720 shares worth $2.01M. The position accounts for 0.29% of the portfolio, ranked #60.

Lebenthal Global Advisors first reported a position in AMGN in Q4 2020 and has held it in 15 quarters since. 3,127 funds tracked by Wall St. Rank hold AMGN as of Q1 2026.

Lebenthal Global Advisors held 5,720 shares of Amgen worth $2.01M as of Q1 2026.
Lebenthal Global Advisors sold 29 Amgen shares in Q1 2026, an estimated $10.3K.
Amgen made up 0.29% of Lebenthal Global Advisors's portfolio in Q1 2026, its #60 holding.
Lebenthal Global Advisors first reported a position in Amgen in Q4 2020 and has held it in 15 quarters since.
3,127 funds tracked by Wall St. Rank held Amgen as of Q1 2026.

Based on Lebenthal Global Advisors's 13F filing for Q1 2026, filed 14 May 2026.